Literature DB >> 21558964

Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children.

Sibylle Koletzko1, Nicola L Jones, Karen J Goodman, Benjamin Gold, Marion Rowland, Samy Cadranel, Sonny Chong, Richard B Colletti, Thomas Casswall, Yoram Elitsur, Jeannette Guarner, Nicolas Kalach, Armando Madrazo, Francis Megraud, Giuseppina Oderda.   

Abstract

OBJECTIVE: As the clinical implications of Helicobacter pylori infection in children and adolescents continue to evolve, ESPGHAN and NASPGHAN jointly renewed clinical guidelines using a standardized evidence-based approach to develop updated recommendations for children and adolescents in North America and Europe.
METHODS: An international panel of 11 pediatric gastroenterologists, 2 epidemiologists, 1 microbiologist, and 1 pathologist was selected by societies that developed evidence-based guidelines based on the Delphi process with anonymous voting in a final face-to-face meeting. A systematic literature search was performed on 8 databases of relevance including publications from January 2000 to December 2009. After excluding nonrelevant publications, tables of evidence were constructed for different focus areas according to the Oxford classification. Statements and recommendations were formulated in the following areas: whom to test, how to test, whom to treat, and how to treat. Grades of evidence were assigned to each recommendation based on the GRADE system.
RESULTS: A total of 2290 publications were identified, from which 738 were finally reviewed. A total of 21 recommendations were generated, and an algorithm was proposed by the joint committee providing evidence-based guidelines on the diagnostic workup and treatment of children with H pylori infection.
CONCLUSIONS: These clinical practice guidelines represent updated, best-available evidence and are meant for children and adolescents living in Europe and North America, but they may not apply to those living on other continents, particularly in developing countries with a high H pylori infection rate and limited health care resources.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21558964     DOI: 10.1097/MPG.0b013e3182227e90

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  69 in total

1.  Management of Helicobacter pylori infection in Latin America: a Delphi technique-based consensus.

Authors:  Antonio Rollan; Juan Pablo Arab; M Constanza Camargo; Roberto Candia; Paul Harris; Catterina Ferreccio; Charles S Rabkin; Juan Cristóbal Gana; Pablo Cortés; Rolando Herrero; Luisa Durán; Apolinaria García; Claudio Toledo; Alberto Espino; Nicole Lustig; Alberto Sarfatis; Catalina Figueroa; Javier Torres; Arnoldo Riquelme
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 2.  What do we know about benefits of H. pylori treatment in childhood?

Authors:  Mónica S Sierra; Emily V Hastings; Karen J Goodman
Journal:  Gut Microbes       Date:  2013-11-06

3.  Paediatric gastroenterology: EGD for children with abdominal pain: the jury is still out.

Authors:  Carlo Di Lorenzo
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-11-05       Impact factor: 46.802

4.  Helicobacter pylori Detection and Eradication in Pediatric and Adult Patients.

Authors:  Benjamin D Gold; Adam B Elfant
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-07

5.  Serum Zinc, Copper, Magnesium and Selenium Levels in Children with Helicobacter Pylori Infection.

Authors:  Nurinnisa Öztürk; Nezahat Kurt; Fatma Betül Özgeriş; Nurcan Kılıç Baygutalp; Mahya Sultan Tosun; Nuri Bakan; Ebubekir Bakan
Journal:  Eurasian J Med       Date:  2015-06

6.  Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA.

Authors:  Jason Y Park; Kerry B Dunbar; Midori Mitui; Christina A Arnold; Dora M Lam-Himlin; Mark A Valasek; Irene Thung; Chinemerem Okwara; Elizabeth Coss; Byron Cryer; Christopher D Doern
Journal:  Dig Dis Sci       Date:  2016-02-29       Impact factor: 3.199

7.  ATP4A autoimmunity and Helicobacter pylori infection in children with type 1 diabetes.

Authors:  A Chobot; J Wenzlau; K Bak-Drabik; J Kwiecien; J Polanska; M Rewers
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

8.  Critical appraisal of clinical practice guidelines in pediatric infectious diseases.

Authors:  Kyle John Wilby; Emily Kathleen Black; Claire MacLeod; Matthew Wiens; Tim T Y Lau; Maria A Paiva; Sean Gorman
Journal:  Int J Clin Pharm       Date:  2015-04-25

Review 9.  Probiotics for the treatment of Helicobacter pylori infection in children.

Authors:  Lucia Pacifico; John Frederick Osborn; Enea Bonci; Sara Romaggioli; Rossella Baldini; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

10.  Safety of first-line triple therapy with a potassium-competitive acid blocker for Helicobacter pylori eradication in children.

Authors:  Chika Kusano; Takuji Gotoda; Sho Suzuki; Hisatomo Ikehara; Mitsuhiko Moriyama
Journal:  J Gastroenterol       Date:  2017-11-07       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.